Ugne Balaseviciute

Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma

S. Friedman, J. Llovet, D. Sia, 2021, Hepatology.

Cabozantinib enhances anti-PD1 activity and elicits a neutrophil-based immune response in hepatocellular carcinoma.

V. Mazzaferro, J. Llovet, F. Miró-Mur, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer

F. Setién, M. Esteller, T. Preiss, 2023, Molecular Cancer.